Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Edema Secondary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02800642
What this trial is testing

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein Occlusion
Bayer 162
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Large-scale testing (Phase 3)Study completedNCT01976338
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 283
Large-scale testing (Phase 3)Looking for participantsNCT06996080
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Who this might be right for
Macular Edema Secondary to Inflammation
Kodiak Sciences Inc 300
Large-scale testing (Phase 3)Study completedNCT05850520
What this trial is testing

Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Who this might be right for
Macular Edema Secondary to Retinal Vein Occlusion
Bayer 892
Large-scale testing (Phase 3)Study completedNCT00942864
What this trial is testing

Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Novartis Korea Ltd. 40
Post-approval studies (Phase 4)Ended earlyNCT01795209
What this trial is testing

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Seoul National University Bundang Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00900887
What this trial is testing

Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema

Who this might be right for
Diabetic RetinopathyMacular Edema
Hospital Juarez de Mexico 84
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Post-approval studies (Phase 4)Study completedNCT03908307
What this trial is testing

Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 150
Not applicableStudy completedNCT07422636
What this trial is testing

Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study

Who this might be right for
Acute Ischemic StrokeReperfusion InjuryCerebral Edema+2 more
University of Florence 213
Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableStudy completedNCT01614509
What this trial is testing

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Yeungnam University College of Medicine 45
Post-approval studies (Phase 4)UnknownNCT05282420
What this trial is testing

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
South Valley University 40
Testing effectiveness (Phase 2)UnknownNCT01830894
What this trial is testing

Feasibility Study of New MRI Protocol in Assessing Early Blood Brain Barrier Disruption (BBBD)in Related to Delay Brain Edema

Who this might be right for
Intra Cerebral Hemorrhage
Sheba Medical Center 30
Large-scale testing (Phase 3)Study completedNCT04740905
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Hoffmann-La Roche 553
Not applicableStudy completedNCT01566526
What this trial is testing

Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Oedema
Allergan 26
Large-scale testing (Phase 3)Study completedNCT01599650
What this trial is testing

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 455
Not applicableStudy completedNCT03161912
What this trial is testing

Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease

Who this might be right for
Macular Edema
Bayer 2,481
Next Page